Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-09 Sale | 2025-12-09 7:07 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $28.83 | $288,289 | 178,801 (Direct) | View |
| 2025-12-08 Sale | 2025-12-08 6:26 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $30 | $300,000 | 195,051 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:18 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $27.64 | $165,835 | 326,945 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:17 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $28 | $1,120,000 | 481,841 (Direct) | View |
| 2025-11-12 Sale | 2025-11-13 5:02 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $26 | $1,040,000 | 521,841 (Direct) | View |
| 2025-10-27 Sale | 2025-10-27 7:56 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,000 | $25 | $200,000 | 224,394 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:13 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $22.41 | $134,439 | 338,445 (Indirect Direct) | View |
| 2025-09-24 Sale | 2025-09-24 7:00 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 35,000 | $24 | $840,000 | 561,841 (Direct) | View |
| 2025-09-16 Sale | 2025-09-16 6:16 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,172 | $21.4 | $174,846 | 197,394 (Direct) | View |
| 2025-09-15 Sale | 2025-09-15 6:37 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $21.85 | $131,101 | 344,445 (Indirect Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:50 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 49,792 | $21 | $1,045,840 | 742,049 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:47 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 40,000 | $21 | $840,102 | 610,004 (Indirect Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:45 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 7,000 | $20 | $140,000 | 240,566 (Direct) | View |
| 2025-08-15 Sale | 2025-08-15 6:13 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $17.23 | $103,380 | 390,445 (Indirect Direct) | View |
| 2025-07-29 Sale | 2025-07-30 5:00 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,322 | $15.23 | $126,751 | 208,163 (Direct) | View |
| 2025-07-25 Sale | 2025-07-25 6:24 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $15.56 | $155,598 | 177,279 (Direct) | View |
| 2025-07-21 Sale | 2025-07-21 7:39 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $15.92 | $875,600 | 409,017 (Indirect Direct) | View |
| 2025-07-15 Sale | 2025-07-17 4:15 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $14.93 | $89,567 | 396,445 (Indirect Direct) | View |
| 2025-06-25 Sale | 2025-06-25 7:44 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $13.86 | $138,642 | 187,279 (Direct) | View |
| 2025-06-24 Sale | 2025-06-25 7:43 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 12,000 | $14.02 | $168,218 | 402,445 (Indirect Direct) | View |
| 2025-06-24 Sale | 2025-06-25 7:42 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $14 | $210,000 | 231,785 (Direct) | View |
| 2025-06-20 Sale | 2025-06-20 8:58 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $12.63 | $694,826 | 464,017 (Indirect Direct) | View |
| 2025-05-27 Sale | 2025-05-27 6:31 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $12.82 | $128,225 | 197,279 (Direct) | View |
| 2025-05-20 Sale | 2025-05-20 5:44 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $12.71 | $699,111 | 519,017 (Indirect Direct) | View |
| 2025-05-15 Purchase | 2025-05-19 5:49 pm | Centessa Pharmaceuticals plc | CNTA | GOYAL ARJUN Director | 462,585 | $12.68 | $5,865,242 | 462,585 (Indirect) | View |
| 2025-05-01 Sale | 2025-05-02 4:17 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 311 | $14 | $4,354 | 414,445 (Indirect Direct) | View |
| 2025-04-25 Sale | 2025-04-29 4:58 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 5,689 | $14 | $79,658 | 720,706 (Indirect Direct) | View |
| 2025-04-25 Sale | 2025-04-25 8:20 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 11,742 | $13.61 | $159,857 | 122,279 (Direct) | View |
| 2025-04-21 Sale | 2025-04-22 5:43 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $12.39 | $681,576 | 259,017 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $9.53 | 195,051 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 195,051 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:18 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 326,945 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:18 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 326,945 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:17 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $9.42 | 481,841 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:17 pm | N/A 2031-05-07 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $0 | 481,841 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 5:02 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $9.42 | 521,841 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 5:02 pm | N/A 2031-05-07 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $0 | 521,841 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-03 4:14 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 593 | $24.9 | 193,801 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $8.01 | 224,394 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 224,394 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:13 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 338,445 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:13 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 338,445 (Direct) | View |
| 2025-09-24 Exercise | 2025-09-24 7:00 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 35,000 | $9.42 | 561,841 (Direct) | View |
| 2025-09-24 Exercise | 2025-09-24 7:00 pm | N/A 2031-05-07 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 35,000 | $0 | 561,841 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-15 6:37 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 344,445 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-15 6:37 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 344,445 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:50 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 24,792 | $8.01 | 742,049 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-11 5:50 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 25,000 | $9.42 | 742,049 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:50 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 49,792 | $0 | 742,049 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:47 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 40,000 | $5.84 | 610,004 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:47 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 40,000 | $0 | 610,004 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:45 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $8.01 | 240,566 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:45 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 240,566 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-15 6:13 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 390,445 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-15 6:13 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 390,445 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-01 5:00 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 597 | $17.17 | 207,566 (Direct) | View |
| 2025-07-25 Exercise | 2025-07-25 6:24 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $3.85 | 177,279 (Direct) | View |
| 2025-07-25 Exercise | 2025-07-25 6:24 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $0 | 177,279 (Direct) | View |
| 2025-07-21 Exercise | 2025-07-21 7:39 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $3.85 | 409,017 (Direct) | View |
| 2025-07-21 Exercise | 2025-07-21 7:39 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $0 | 409,017 (Direct) | View |
| 2025-07-15 Exercise | 2025-07-17 4:15 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 396,445 (Direct) | View |
| 2025-07-15 Exercise | 2025-07-17 4:15 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 396,445 (Direct) | View |
| 2025-06-25 Exercise | 2025-06-25 7:44 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $3.85 | 187,279 (Direct) | View |
| 2025-06-25 Exercise | 2025-06-25 7:44 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $0 | 187,279 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:43 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 12,000 | $5.84 | 402,445 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:43 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 12,000 | $0 | 402,445 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:42 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $3.85 | 231,785 (Direct) | View |
| 2025-06-24 Exercise | 2025-06-25 7:42 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 15,000 | $0 | 231,785 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:13 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | GOYAL ARJUN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:13 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | Hedley Mary Lynne Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:12 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | Hukkelhoven Mathias Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:11 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:11 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | Stuckley Carol Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 4:10 pm | N/A 2035-06-20 | Centessa Pharmaceuticals plc | CNTA | ZBAR BRETT I W Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2025-06-24 4:08 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 0 | $0 | 539,910 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-20 8:58 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $3.85 | 464,017 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-20 8:58 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $0 | 464,017 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-03 4:26 pm | N/A 2035-06-02 | Centessa Pharmaceuticals plc | CNTA | Deferiere Raphael Chief Accounting Officer | 165,000 | $0 | 165,000 (Direct) | View |
| 2025-05-27 Exercise | 2025-05-27 6:31 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $3.85 | 197,279 (Direct) | View |
| 2025-05-27 Exercise | 2025-05-27 6:31 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 10,000 | $0 | 197,279 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-20 5:44 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $3.85 | 519,017 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-20 5:44 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 55,000 | $0 | 519,017 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-02 4:17 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 311 | $5.84 | 414,445 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-02 4:17 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 311 | $0 | 414,445 (Direct) | View |
| 2025-04-25 Exercise | 2025-04-29 4:58 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 5,689 | $5.84 | 720,706 (Direct) | View |
| 2025-04-25 Exercise | 2025-04-29 4:58 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 5,689 | $0 | 720,706 (Direct) | View |